Lifan Wang

518 total citations
34 papers, 347 citations indexed

About

Lifan Wang is a scholar working on Epidemiology, Molecular Biology and Surgery. According to data from OpenAlex, Lifan Wang has authored 34 papers receiving a total of 347 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Lifan Wang's work include Radiomics and Machine Learning in Medical Imaging (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Lifan Wang is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers) and Liver Disease Diagnosis and Treatment (6 papers). Lifan Wang collaborates with scholars based in China, Israel and Germany. Lifan Wang's co-authors include Wei Han, Yangyang Wang, Linhan Zhang, Haohao Yin, Chong-Ke Zhao, Liping Sun, Yong Li, Ping Li, Mengjiao Wang and Peng Liu and has published in prestigious journals such as Nature Communications, Chemical Engineering Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Lifan Wang

30 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lifan Wang China 11 147 75 73 68 65 34 347
Shi Zhou China 13 153 1.0× 107 1.4× 32 0.4× 47 0.7× 76 1.2× 38 396
Lingxuan Zhu China 11 109 0.7× 47 0.6× 79 1.1× 18 0.3× 30 0.5× 27 317
Yukiko Nagashima Japan 12 94 0.6× 84 1.1× 90 1.2× 35 0.5× 94 1.4× 34 331
Yanya Lin China 3 128 0.9× 81 1.1× 208 2.8× 35 0.5× 28 0.4× 7 349
Xiaojun Liu China 10 129 0.9× 55 0.7× 99 1.4× 44 0.6× 18 0.3× 30 365
Baojin Wang China 12 169 1.1× 112 1.5× 36 0.5× 25 0.4× 20 0.3× 25 319

Countries citing papers authored by Lifan Wang

Since Specialization
Citations

This map shows the geographic impact of Lifan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifan Wang more than expected).

Fields of papers citing papers by Lifan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lifan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifan Wang. The network helps show where Lifan Wang may publish in the future.

Co-authorship network of co-authors of Lifan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Lifan Wang. A scholar is included among the top collaborators of Lifan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lifan Wang. Lifan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Xiao, Daohui Yang, Chong-Ke Zhao, et al.. (2025). Dynamic contrast-enhanced ultrasound perfusion analysis for preoperative prediction of aggressive hepatocellular carcinoma subtypes. Insights into Imaging. 16(1). 202–202.
3.
Zhang, Ruiyan, et al.. (2025). Lipidomics-based natural products for chronic kidney disease treatment. Heliyon. 11(1). e41620–e41620. 3 indexed citations
4.
Shen, Yuting, Chong-Ke Zhao, Xiao‐Long Li, et al.. (2025). Cascade‐Responsive Nanoprodrug Disrupts Immune‐Fibroblast Communications for Potentiated Cancer Mechanoimmunotherapy. Advanced Healthcare Materials. 14(11). e2500176–e2500176. 3 indexed citations
5.
Yin, Haohao, Jifeng Yu, Bing Xiong, et al.. (2024). Quantitative US fat fraction for noninvasive assessment of hepatic steatosis in suspected metabolic-associated fatty liver disease. Insights into Imaging. 15(1). 159–159. 3 indexed citations
6.
Zhao, Chong‐Ke, Xiao‐Long Li, Haohao Yin, et al.. (2024). Subtype prediction of intrahepatic cholangiocarcinoma using dynamic contrast-enhanced ultrasound. Insights into Imaging. 15(1). 119–119.
7.
Yu, Jifeng, Haohao Yin, Xiaoxia Han, et al.. (2024). Exploiting a tumor softening targeted bomb for mechanical gene therapy of chemoresistant Triple-Negative breast cancer. Chemical Engineering Journal. 498. 155217–155217. 2 indexed citations
9.
Wang, Jingjing, et al.. (2024). Exploring potential targets for natural product therapy of DN: the role of SUMOylation. Frontiers in Pharmacology. 15. 1432724–1432724. 1 indexed citations
10.
Lin, Zhengjun, Mingrui Wang, Lifan Wang, et al.. (2024). Identification and verification of PTPN3 as a novel biomarker in predicting cancer prognosis, immunity, and immunotherapeutic efficacy. European journal of medical research. 29(1). 12–12. 3 indexed citations
11.
Wang, Jingjing, Rui Zhang, Hailing Zhao, et al.. (2023). Research progress on Cornus officinalis and its active compounds in the treatment of diabetic nephropathy. Frontiers in Pharmacology. 14. 1207777–1207777. 13 indexed citations
13.
Wang, Lifan, Qiao Wang, Feng Mao, et al.. (2023). Risk stratification of gallbladder masses by machine learning-based ultrasound radiomics models: a prospective and multi-institutional study. European Radiology. 33(12). 8899–8911. 11 indexed citations
14.
Wang, Lifan, et al.. (2023). Risk stratification model for incidentally detected gallbladder polyps: A multicentre study. European Journal of Radiology. 170. 111244–111244. 4 indexed citations
15.
Yu, Jifeng, Bangguo Zhou, Shen Zhang, et al.. (2022). Design of a self-driven probiotic-CRISPR/Cas9 nanosystem for sono-immunometabolic cancer therapy. Nature Communications. 13(1). 7903–7903. 61 indexed citations
16.
Wang, Lifan, Qiao Wang, Xiao‐Long Li, et al.. (2021). Value of High-Frequency Ultrasound for Differentiating Invasive Basal Cell Carcinoma from Non-invasive Types. Ultrasound in Medicine & Biology. 47(10). 2910–2920. 16 indexed citations
17.
Liu, Peng, et al.. (2021). Morroniside Promotes PGC‐1α‐Mediated Cholesterol Efflux in Sodium Palmitate or High Glucose‐Induced Mouse Renal Tubular Epithelial Cells. BioMed Research International. 2021(1). 9942152–9942152. 22 indexed citations
18.
Wang, Qiao, Hui Bao, Le‐Hang Guo, et al.. (2021). Quantitative assessment of crystal dissolution in gout during urate-lowering therapy with computer-aided MicroPure imaging: a cohort study. Annals of Translational Medicine. 9(18). 1444–1444. 1 indexed citations
19.
Lou, Shenghan, et al.. (2017). Combination therapy of anabolic and nonbisphosphonates antiresorptive agents for the treatment of osteoporosis. Medicine. 96(52). e9534–e9534. 3 indexed citations
20.
Wang, Hong, Fenglin Cao, Jinmei Li, et al.. (2014). Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia. International Journal of Hematology. 100(2). 165–170. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026